Law360, Boston (January 24, 2018, 8:54 PM EST) -- Massachusetts' new top federal prosecutor said Wednesday he plans to continue a crackdown on pharmaceutical and biotechnology companies accused of shelling out cash to patient-assistance charities on the condition that the donations be funneled only to patients who buy the donor's products.
At his first media availability since taking office last month, U.S. Attorney Andrew Lelling said he had tried to balance patients' needs for affordable medication against what he called a "problem" of crooked donations.
"It's unfortunate that the drug companies have put us in this position, but it is something that we're going to fix, and we try to...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!